SE0102184D0 - New subject-matter - Google Patents
New subject-matterInfo
- Publication number
- SE0102184D0 SE0102184D0 SE0102184A SE0102184A SE0102184D0 SE 0102184 D0 SE0102184 D0 SE 0102184D0 SE 0102184 A SE0102184 A SE 0102184A SE 0102184 A SE0102184 A SE 0102184A SE 0102184 D0 SE0102184 D0 SE 0102184D0
- Authority
- SE
- Sweden
- Prior art keywords
- subject matter
- new subject
- mesotocin
- oxytocin
- tri
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102184A SE0102184D0 (sv) | 2001-06-19 | 2001-06-19 | New subject-matter |
| DE60224280T DE60224280D1 (de) | 2001-06-19 | 2002-06-19 | Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis |
| AT02739051T ATE382054T1 (de) | 2001-06-19 | 2002-06-19 | Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis |
| US10/481,623 US7714105B2 (en) | 2001-06-19 | 2002-06-19 | Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| EP02739051A EP1409518B1 (de) | 2001-06-19 | 2002-06-19 | Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis |
| PCT/SE2002/001207 WO2002102832A1 (en) | 2001-06-19 | 2002-06-19 | Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102184A SE0102184D0 (sv) | 2001-06-19 | 2001-06-19 | New subject-matter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0102184D0 true SE0102184D0 (sv) | 2001-06-19 |
Family
ID=20284539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0102184A SE0102184D0 (sv) | 2001-06-19 | 2001-06-19 | New subject-matter |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7714105B2 (de) |
| EP (1) | EP1409518B1 (de) |
| AT (1) | ATE382054T1 (de) |
| DE (1) | DE60224280D1 (de) |
| SE (1) | SE0102184D0 (de) |
| WO (1) | WO2002102832A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4654418B2 (ja) | 2004-03-31 | 2011-03-23 | 独立行政法人産業技術総合研究所 | 上皮系細胞増殖促進剤 |
| WO2011027060A2 (fr) | 2009-09-04 | 2011-03-10 | Centre National De La Recherche Scientifique - Crns - | Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique |
| SE536091C2 (sv) | 2011-04-14 | 2013-04-30 | Pep Tonic Medical Ab | Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter |
| SG11201705591PA (en) | 2015-01-07 | 2017-08-30 | Trigemina Inc | Magnesium-containing oxytocin formulations and methods of use |
| HUE070412T2 (hu) | 2016-04-12 | 2025-06-28 | Tonix Pharma Ltd | Magnézium tartalmú oxitocin készítmények és alkamazási eljárásaik |
| JP6527996B2 (ja) * | 2017-09-12 | 2019-06-12 | 株式会社 金冠堂 | Fgf活性に影響を与えるジペプチド |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4271068A (en) * | 1968-05-10 | 1981-06-02 | Ciba-Geigy Corporation | Process for the manufacture of cystine-containing peptides |
| EP0146113A3 (de) | 1983-12-15 | 1987-08-19 | Dieter Aderhold | Wirkstoff und therapeutisches Mittel zur Behandlung von Fehlfunktionen des Diencephalon, von Nervenerkrankungen und Erkrankungen der Haut |
| US5767083A (en) * | 1994-05-04 | 1998-06-16 | Innapharma, Inc. | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| SE9803271D0 (sv) | 1998-09-25 | 1998-09-25 | Kerstin Uvnaes Moberg | A drug for well-being |
-
2001
- 2001-06-19 SE SE0102184A patent/SE0102184D0/xx unknown
-
2002
- 2002-06-19 US US10/481,623 patent/US7714105B2/en not_active Expired - Lifetime
- 2002-06-19 WO PCT/SE2002/001207 patent/WO2002102832A1/en not_active Ceased
- 2002-06-19 EP EP02739051A patent/EP1409518B1/de not_active Expired - Lifetime
- 2002-06-19 AT AT02739051T patent/ATE382054T1/de not_active IP Right Cessation
- 2002-06-19 DE DE60224280T patent/DE60224280D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1409518B1 (de) | 2007-12-26 |
| DE60224280D1 (de) | 2008-02-07 |
| ATE382054T1 (de) | 2008-01-15 |
| EP1409518A1 (de) | 2004-04-21 |
| US20040259805A1 (en) | 2004-12-23 |
| US7714105B2 (en) | 2010-05-11 |
| WO2002102832A1 (en) | 2002-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| CY1108547T1 (el) | Αναλογα σωματοστατινης | |
| NO20052306D0 (no) | Dispergerbare farmasoytiske blandinger. | |
| TW200505875A (en) | Novel compounds | |
| IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| NO992102D0 (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
| BRPI0508700A (pt) | uso de sns-595, composição farmacêutica, e, pó liofilizado | |
| ITMI20031570A1 (it) | Composizione per uso dietetico, farmaceutico o cosmetico | |
| EP1423137A4 (de) | Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte | |
| PL374080A1 (en) | Processes for the preparation of fibrinogen | |
| PL1622939T3 (pl) | Aktywne warianty białka wiążącego IL-18 i ich medyczne zastosowania | |
| DE50113345D1 (de) | Arginin-mimetika als faktor xa-inhibitoren | |
| CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
| ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
| PT1290160E (pt) | Polipeptideos pellino humanos | |
| SE0102184D0 (sv) | New subject-matter | |
| UA107177C2 (uk) | Імуногенна композиція цвс2 та спосіб приготування такої композиції | |
| BRPI0408446A (pt) | tablete de limpeza | |
| TW200503783A (en) | Oral pharmaceutical preparation for proton pump antagonists | |
| SE0101220D0 (sv) | New use | |
| WO2005035746A3 (en) | Medical use of tbk-1 or of inhibitors thereof | |
| DK1399143T3 (da) | Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni | |
| DK1626726T3 (da) | Anvendelse af lornoxicam eller lornoxicam-analoger | |
| IT1338456B1 (it) | Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato |